Spyre Therapeutics
SYRE
SYRE
54 hedge funds and large institutions have $601M invested in Spyre Therapeutics in 2023 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
+25
Holders Change %
+86.21%
% of All Funds
0.79%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.04%
New
29
Increased
16
Reduced
5
Closed
4
Calls
$44K
Puts
–
Net Calls
+$44K
Net Calls Change
+$11K
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$79.7M |
| 2 |
PA
2
Perceptive Advisors
New York
|
$56.1M |
| 3 |
RI
3
RTW Investments
New York
|
$48M |
| 4 |
VA
4
VR Adviser
New York
|
$51.1M |
| 5 |
DTC
5
Deep Track Capital
Greenwich,
Connecticut
|
$42M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
JPMorgan Chase & Co
New York
| $882 | – | – | – |
|
52
Wells Fargo
San Francisco,
California
| $495 | +$22 | +1 | +5% |
|
|
PCWA
53
Pacific Capital Wealth Advisors
Corona,
California
| $172 | +$172 | +8 | New |
|
|
PA
54
Parallel Advisors
San Francisco,
California
| $22 | +$22 | +1 | New |
|
|
RSCM
55
Rock Springs Capital Management
Baltimore,
Maryland
| – | -$1.67M | -136,556 | Closed |
|
|
ACM
56
Aisling Capital Management
New York
| – | -$829K | -67,645 | Closed |
|
|
YF
57
Yu Fan
| – | -$348K | -20,592 | Closed |
|
58
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$5K | -437 | Closed |
|